-
Forward Look
Be Alert to Heart HealthRisk of stroke and heart disease increases after a cancer diagnosis.
by Robin Meadows
-
Forward Look
FDA Approves First Biosimilar Cancer TherapyNew product expected to be less expensive.
by Christina Bennett
-
Forward Look
Tracking Treatment Side Effects Benefits Cancer PatientsQuick response to symptoms improves quality of life and survival.
by Cameron Walker
-
Forward Look
Young Survivors at Risk for HPV-Related CancersStudy finds low vaccination rates among teen survivors.
by Kate Yandell
-
Targeting Brain Cancer
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
-
Healthy Habits
A Bacterial LinkThe microbes living in your gut may explain how diet influences colorectal cancer risk.
by Lori Miller Kase
-
Healthy Habits
Another Reason to FlossGum disease is associated with increased cancer risk.
by Kendall K. Morgan
-
Q&A
Why Fat MattersCancer epidemiologist Cornelia Ulrich discusses research that explores how fat cells and cancer cells communicate.
by Marci A. Landsmann
-
Study Shows Minority Participation in Clinical Trials May Be Declining
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Healthy Habits
A Virtuous CycleBicycling to work can be a way to build exercise into your day.
by Kate Yandell
Cancer Talk
Biotin Supplements Can Skew Cancer Lab Results
Products containing biotin can alter lab tests for people during and after cancer treatment.
by Laura Gesualdi Gilmore
Connecting More Patients to Cancer Clinical TrialsAACR conference brings experts together to discuss strategies to reach people historically left out of cancer research.
by Eric Fitzsimmons
Treatment Combination Improves Survival in EGFR-positive Lung CancerAdding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
